SCHEMBL20127355

SCHEMBL20127355

c1ccc2cc(-c3c4ccccc4c(-c4ccc5c(c4)oc4cc(-c6ccc7oc8ccccc8c7c6)c6ccccc6c45)c4ccccc34)ccc2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 1/20 0.37
MAPT P10636 4/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
ALDH1A1 P00352 3/20 0.36
HPGD P15428 3/20 0.36
AHR P35869 2/20 0.36
KDM4E B2RXH2 2/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
GPR84 Q9NQS5 1/20 0.36
GSTP1 P09211 1/20 0.35
CYP1A1 P04798 1/20 0.34
CYP1B1 Q16678 1/20 0.34
CASP3 P42574 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127349 0.94 MAPT (0.39) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL20127360 0.92 GSTP1 (0.40) HCRTR1ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL19076513 0.91 AHR (0.39) HCRTR1MAPTMEN1KMT2AALDH1A1
SCHEMBL19076496 0.90 MAOA (0.38) HCRTR1MAPTMEN1KMT2AALDH1A1
SCHEMBL20127351 0.90 GPR84 (0.40) MAPTALDH1A1HPGDAHRKDM4E
SCHEMBL19076497 0.89 GPR84 (0.39) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL23427346 0.88 CYP1A1 (0.41) HCRTR1MAPTMEN1KMT2AALDH1A1
SCHEMBL13507104 0.88 CYP1A1 (0.41) HCRTR1ALDH1A1HPGDAHRNPC1
SCHEMBL19076388 0.88 AHR (0.36) HCRTR1MAPTMEN1KMT2AALDH1A1
SCHEMBL19076495 0.88 CYP1A1 (0.37) HCRTR1AHRNPC1RAB9ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 HCRTR1 1635/4885MAPT 3500/4885MEN1 3297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.